UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 298

Sortiert nach

Oxidized mitochondrial DNA sensing by STING signaling promotes the antitumor effect of an irradiated immunogenic cancer cell vaccine

Cellular & molecular immunology, 2021-09, Vol.18 (9), p.2211-2223

2021

Volltextzugriff (PDF)

Primary Tumor Standardized Uptake Value Measured on F18-Fluorodeoxyglucose Positron Emission Tomography Is of Prediction Value for Survival and Local Control in Non–Small-Cell Lung Cancer Receiving Radiotherapy: Meta-Analysis

Journal of thoracic oncology, 2014-06, Vol.9 (6), p.834-842

2014

Volltextzugriff (PDF)

Organoid technology and applications in lung diseases: Models, mechanism research and therapy opportunities

Frontiers in bioengineering and biotechnology, 2022-12, Vol.10, p.1066869-1066869

2022

Volltextzugriff (PDF)

Targeting the vascular and perivascular niches as a regenerative therapy for lung and liver fibrosis

Science translational medicine, 2017-08, Vol.9 (405)

2017

Volltextzugriff (PDF)

Cranial radiation therapy with hippocampus avoidance in lung cancer treatment: systematic review and meta-analysis

Frontiers in oncology, 2023-10, Vol.13, p.1268754-1268754

2023

Volltextzugriff (PDF)

Epigenetic reprogramming in small cell lung cancer

Cancer biology & medicine, 2022-08, Vol.19 (8), p.1111-1116

2022

Volltextzugriff (PDF)

An organoid-based drug screening identified a menin-MLL inhibitor for endometrial cancer through regulating the HIF pathway

Cancer gene therapy, 2021-02, Vol.28 (1-2), p.112-125

2021

Volltextzugriff (PDF)

Identifying a confused cell identity for esophageal squamous cell carcinoma

Signal transduction and targeted therapy, 2022-04, Vol.7 (1), p.122-122, Article 122

2022

Volltextzugriff (PDF)

Incidence and risk factors of acute kidney injury in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis

Frontiers in immunology, 2023-05, Vol.14, p.1173952-1173952

2023

Volltextzugriff (PDF)

Synergy between peroxisome proliferator‐activated receptor γ agonist and radiotherapy in cancer

Cancer science, 2018-07, Vol.109 (7), p.2243-2255

2018

Volltextzugriff (PDF)

Involved-field irradiation or elective-nodal irradiation in neoadjuvant chemo-radiotherapy for locally-advanced esophageal cancer: comprehensive analysis for dosimetry, treatment-related complications, impact on lymphocyte, patterns of failure and survival

Frontiers in oncology, 2023-10, Vol.13, p.1274924-1274924

2023

Volltextzugriff (PDF)

A New Type of Endometrial Cancer Models in Mice Revealing the Functional Roles of Genetic Drivers and Exploring their Susceptibilities

Advanced science, 2023-08, Vol.10 (24), p.e2300383-n/a

2023

Volltextzugriff (PDF)

The association between TGF-β1 polymorphisms and radiation pneumonia in lung cancer patients treated with definitive radiotherapy: a meta-analysis

PloS one, 2014-03, Vol.9 (3), p.e91100

2014

Volltextzugriff (PDF)

Chemoimmunotherapy combined with consolidative thoracic radiotherapy for extensive-stage small cell lung cancer: A systematic review and meta-analysis

Radiotherapy and oncology, 2024-01, Vol.190, p.110014, Article 110014

2024

Volltextzugriff (PDF)

Diverse regulated cell death modes predict the immune microenvironment and drug sensitivity in lung adenocarcinoma

Journal of cellular physiology, 2023-11, Vol.238 (11), p.2570-2585

2023

Volltextzugriff (PDF)

Immunogenetic variations predict immune-related adverse events for PD-1/PD-L1 inhibitors

European journal of cancer (1990), 2023-05, Vol.184, p.124-136

2023

Volltextzugriff (PDF)

HIF-1-dependent heme synthesis promotes gemcitabine resistance in human non-small cell lung cancers via enhanced ABCB6 expression

Cellular and molecular life sciences : CMLS, 2022-06, Vol.79 (6), p.343-343, Article 343

2022

Volltextzugriff (PDF)

DNMT3AR882H accelerates angioimmunoblastic T-cell lymphoma in mice

Oncogene, 2023-06, Vol.42 (23), p.1940-1950

2023

Volltextzugriff (PDF)

First-line treatment of driver gene-negative metastatic lung adenocarcinoma with malignant pleural effusion: Should chemotherapy be combined with an immune checkpoint inhibitor or bevacizumab?

Investigational new drugs, 2024-04, Vol.42 (2), p.196-206

2024

Volltextzugriff (PDF)

Immunogenetic polymorphisms predict therapeutic efficacy and survival outcomes in tumor patients receiving PD-1/PD-L1 blockade

International immunopharmacology, 2023-08, Vol.121, p.110469-110469, Article 110469

2023

Volltextzugriff (PDF)

Association of PDCD1 and CTLA-4 Gene Expression with Clinicopathological Factors and Survival in Non–Small-Cell Lung Cancer: Results from a Large and Pooled Microarray Database

Journal of thoracic oncology, 2015-07, Vol.10 (7), p.1020-1026

2015

Volltextzugriff (PDF)

Bevacizumab radiosensitizes non-small cell lung cancer xenografts by inhibiting DNA double-strand break repair in endothelial cells

Cancer letters, 2015-08, Vol.365 (1), p.79-88

2015

Volltextzugriff (PDF)

Expression and prognosis analyses of Dectin-1 cluster genes in patients with lung adenocarcinoma (LUAD) and the association with immune checkpoint molecules

Biocell, 2021-01, Vol.45 (3), p.649-663

2021

Volltextzugriff (PDF)

Ethyl pyruvate alleviates radiation-induced lung injury in mice

Biomedicine & pharmacotherapy, 2017-08, Vol.92, p.468-478

2017

Volltextzugriff (PDF)

1 – 25 von 298

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(277)
Mit Volltextzugriff
(285)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(247)
Life Sciences & Biomedicine
(158)
Physical Sciences
(79)
Humans
(74)
Technology
(58)
Chemistry
(51)
Female
(34)
Engineering
(32)
Animals
(31)
Male
(31)
Environmental Sciences
(30)
Environmental Sciences & Ecology
(30)
Oncology
(30)
Materials Science
(28)
Cancer
(27)
Science & Technology - Other Topics
(26)
Materials Science, Multidisciplinary
(23)
Mice
(23)
Chemistry, Multidisciplinary
(22)
Lung Cancer
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Oxidized mitochondrial DNA sensing by STING signaling promotes the antitumor effect of an irradiated immunogenic cancer cell vaccine

Primary Tumor Standardized Uptake Value Measured on F18-Fluorodeoxyglucose Positron Emission Tomography Is of Prediction Value for Survival and Local Control in Non–Small-Cell Lung Cancer Receiving Radiotherapy: Meta-Analysis

Organoid technology and applications in lung diseases: Models, mechanism research and therapy opportunities

Targeting the vascular and perivascular niches as a regenerative therapy for lung and liver fibrosis

Cranial radiation therapy with hippocampus avoidance in lung cancer treatment: systematic review and meta-analysis

Epigenetic reprogramming in small cell lung cancer

An organoid-based drug screening identified a menin-MLL inhibitor for endometrial cancer through regulating the HIF pathway

Identifying a confused cell identity for esophageal squamous cell carcinoma

Incidence and risk factors of acute kidney injury in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis

Synergy between peroxisome proliferator‐activated receptor γ agonist and radiotherapy in cancer

Involved-field irradiation or elective-nodal irradiation in neoadjuvant chemo-radiotherapy for locally-advanced esophageal cancer: comprehensive analysis for dosimetry, treatment-related complications, impact on lymphocyte, patterns of failure and survival

A New Type of Endometrial Cancer Models in Mice Revealing the Functional Roles of Genetic Drivers and Exploring their Susceptibilities

The association between TGF-β1 polymorphisms and radiation pneumonia in lung cancer patients treated with definitive radiotherapy: a meta-analysis

Chemoimmunotherapy combined with consolidative thoracic radiotherapy for extensive-stage small cell lung cancer: A systematic review and meta-analysis

Diverse regulated cell death modes predict the immune microenvironment and drug sensitivity in lung adenocarcinoma

Immunogenetic variations predict immune-related adverse events for PD-1/PD-L1 inhibitors

HIF-1-dependent heme synthesis promotes gemcitabine resistance in human non-small cell lung cancers via enhanced ABCB6 expression

DNMT3AR882H accelerates angioimmunoblastic T-cell lymphoma in mice

First-line treatment of driver gene-negative metastatic lung adenocarcinoma with malignant pleural effusion: Should chemotherapy be combined with an immune checkpoint inhibitor or bevacizumab?

Immunogenetic polymorphisms predict therapeutic efficacy and survival outcomes in tumor patients receiving PD-1/PD-L1 blockade

Association of PDCD1 and CTLA-4 Gene Expression with Clinicopathological Factors and Survival in Non–Small-Cell Lung Cancer: Results from a Large and Pooled Microarray Database

Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer

Bevacizumab radiosensitizes non-small cell lung cancer xenografts by inhibiting DNA double-strand break repair in endothelial cells

Expression and prognosis analyses of Dectin-1 cluster genes in patients with lung adenocarcinoma (LUAD) and the association with immune checkpoint molecules

Ethyl pyruvate alleviates radiation-induced lung injury in mice

Suchergebnisse filtern